
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.030 | 4.030 | 0.000 |
Stocks | 95.970 | 95.970 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.551 | 17.888 |
Price to Book | 4.074 | 3.722 |
Price to Sales | 5.455 | 5.291 |
Price to Cash Flow | 16.122 | 13.925 |
Dividend Yield | 0.581 | 0.525 |
5 Years Earnings Growth | 7.042 | 16.265 |
Number of long holdings: 82
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 7.48 | 107.25 | -4.57% | |
Amgen | US0311621009 | 6.31 | 294.39 | -4.99% | |
Regeneron Pharma | US75886F1075 | 5.92 | 573.45 | -6.09% | |
Vertex | US92532F1003 | 5.83 | 474.62 | -1.94% | |
Alnylam | US02043Q1076 | 3.99 | 235.74 | -10.08% | |
BioNTech | US09075V1026 | 3.26 | 88.05 | -4.30% | |
Insmed | US4576693075 | 2.73 | 69.18 | -5.66% | |
Ascendis Pharma AS | US04351P1012 | 2.52 | 142.67 | -4.94% | |
BeiGene ADS | US07725L1026 | 2.48 | 238.51 | -9.76% | |
Biomarin Pharma | US09061G1013 | 2.34 | 60.26 | -10.70% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities R EUR Acc | 2.61B | 0.45 | 14.10 | 12.69 | ||
Cleome Index USA Equities Y EUR Acc | 2.61B | 0.28 | 12.89 | 11.80 | ||
Cleome Index USA Equities Z EUR Acc | 2.61B | 0.50 | 14.44 | 13.08 | ||
LU2197358042 | 2.61B | 0.49 | 14.35 | - | ||
Candriam Equities L Global Demograp | 1.96B | 1.94 | 10.57 | 10.05 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review